Classifications

• • G—PHYSICS
  • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
  • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
  • G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
  • G16B25/10—Gene or protein expression profiling; Expression-ratio estimation or normalisation
• • C—CHEMISTRY; METALLURGY
  • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
  • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
  • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
  • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
  • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
  • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
  • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
• • G—PHYSICS
  • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
  • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
  • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
• • C—CHEMISTRY; METALLURGY
  • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
  • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
  • C12Q2537/00—Reactions characterised by the reaction format or use of a specific feature
  • C12Q2537/10—Reactions characterised by the reaction format or use of a specific feature the purpose or use of
  • C12Q2537/143—Multiplexing, i.e. use of multiple primers or probes in a single reaction, usually for simultaneously analyse of multiple analysis
• • C—CHEMISTRY; METALLURGY
  • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
  • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
  • C12Q2600/00—Oligonucleotides characterized by their use
  • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
• • C—CHEMISTRY; METALLURGY
  • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
  • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
  • C12Q2600/00—Oligonucleotides characterized by their use
  • C12Q2600/112—Disease subtyping, staging or classification
• • C—CHEMISTRY; METALLURGY
  • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
  • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
  • C12Q2600/00—Oligonucleotides characterized by their use
  • C12Q2600/158—Expression markers
• • G—PHYSICS
  • G01—MEASURING; TESTING
  • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
  • G01N2800/00—Detection or diagnosis of diseases
  • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

• Health & Medical Sciences (AREA)
• Life Sciences & Earth Sciences (AREA)
• Chemical & Material Sciences (AREA)
• Genetics & Genomics (AREA)
• Engineering & Computer Science (AREA)
• Proteomics, Peptides & Aminoacids (AREA)
• Organic Chemistry (AREA)
• Physics & Mathematics (AREA)
• Pathology (AREA)
• Zoology (AREA)
• Analytical Chemistry (AREA)
• Wood Science & Technology (AREA)
• Immunology (AREA)
• General Health & Medical Sciences (AREA)
• Bioinformatics & Cheminformatics (AREA)
• Biophysics (AREA)
• Biotechnology (AREA)
• Molecular Biology (AREA)
• Medical Informatics (AREA)
• Oncology (AREA)
• Biochemistry (AREA)
• Microbiology (AREA)
• General Engineering & Computer Science (AREA)
• Hospice & Palliative Care (AREA)
• Bioinformatics & Computational Biology (AREA)
• Evolutionary Biology (AREA)
• Spectroscopy & Molecular Physics (AREA)
• Theoretical Computer Science (AREA)
• Artificial Intelligence (AREA)
• Bioethics (AREA)
• Computer Vision & Pattern Recognition (AREA)
• Data Mining & Analysis (AREA)
• Databases & Information Systems (AREA)
• Epidemiology (AREA)
• Evolutionary Computation (AREA)
• Public Health (AREA)
• Software Systems (AREA)
• Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
• Apparatus For Radiation Diagnosis (AREA)
• Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Applications Claiming Priority (2)

Publications (1)

Family

ID=65686083

Family Applications (1)

Country Status (15)

Families Citing this family (9)

Family Cites Families (12)

• 2019
  • 2019-02-21 US US16/281,315 patent/US11410748B2/en active Active
  • 2019-02-21 JP JP2020544261A patent/JP7662337B2/ja active Active
  • 2019-02-21 CN CN201980027332.XA patent/CN112673115B/zh active Active
  • 2019-02-21 EP EP25156901.8A patent/EP4538393A3/en active Pending
  • 2019-02-21 PL PL19709298.4T patent/PL3755816T3/pl unknown
  • 2019-02-21 KR KR1020267002939A patent/KR20260018206A/ko active Pending
  • 2019-02-21 DK DK19709298.4T patent/DK3755816T3/da active
  • 2019-02-21 BR BR112020016989-7A patent/BR112020016989A2/pt unknown
  • 2019-02-21 SG SG11202007922XA patent/SG11202007922XA/en unknown
  • 2019-02-21 CN CN202510096498.4A patent/CN119932188A/zh active Pending
  • 2019-02-21 CA CA3091647A patent/CA3091647A1/en active Pending
  • 2019-02-21 WO PCT/US2019/018878 patent/WO2019165021A1/en not_active Ceased
  • 2019-02-21 KR KR1020207026864A patent/KR102921718B1/ko active Active
  • 2019-02-21 ES ES19709298T patent/ES3023842T3/es active Active
  • 2019-02-21 EP EP19709298.4A patent/EP3755816B1/en active Active
  • 2019-02-21 MX MX2020008702A patent/MX2020008702A/es unknown
  • 2019-02-21 AU AU2019224025A patent/AU2019224025B2/en active Active
• 2020
  • 2020-08-17 IL IL276748A patent/IL276748A/en unknown
  • 2020-08-20 MX MX2025000449A patent/MX2025000449A/es unknown
• 2022
  • 2022-07-26 US US17/815,102 patent/US20230298695A1/en not_active Abandoned
• 2025
  • 2025-04-03 JP JP2025061707A patent/JP2025096376A/ja active Pending
  • 2025-04-18 US US19/182,880 patent/US20260066046A1/en active Pending
  • 2025-09-26 AU AU2025238057A patent/AU2025238057A1/en active Pending

Also Published As

Similar Documents